NTRK2 and neoplasm: Does tumor-derived kynurenine drive platelet AhR/CYP1B1 to increase the NAS/melatonin ratio, with the autocrine effects of NAS activating the truncated TrkB-T, leading to platelet release of pro-inflammatory cytokines and pro-angiogenic factors [92]?